Skip to content

Legato Capital Management LLC: EB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Legato Capital Management LLC on EB, newest first. How the timeline and the estimate are built.

Legato Capital Management LLC held 0 EB shares at 2025-09-30 per its 13F-HR filed 2025-11-12.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -14,269 shares

    13F-HR 0001528621-25-001176 filed by Legato Capital Management LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 14,269 shares
    Change vs previous 13F -7,310 shares

    <0.01% of the 13F portfolio, value $37,527.

    13F-HR 0001528621-25-000842 filed by Legato Capital Management LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 21,579 shares
    Change vs previous 13F -2,844 shares

    0.01% of the 13F portfolio, value $45,532.

    13F-HR 0001821268-25-000098 filed by Legato Capital Management LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 24,423 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $82,061.

    13F-HR 0001821268-25-000016 filed by Legato Capital Management LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 24,423 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $66,675.

    13F-HR 0001821268-24-000287 filed by Legato Capital Management LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).